12:14:17 EDT Mon 29 Apr 2024
Enter Symbol
or Name
USA
CA



Genview Capital Corp
Symbol GVW
Shares Issued 8,400,000
Close 2015-05-08 C$ 0.025
Market Cap C$ 210,000
Recent Sedar Documents

ORIGINAL: Genview Capital QT target launches new product line

2015-10-13 11:59 ET - News Release

Received by email:

File: 20151002 Press Release.doc

GENVIEW CAPITAL CORP.
FOR IMMEDIATE RELEASE

Contact: Investor Relations                                 Tuesday, October 13, 2015
 Phone: 604-684-2181                                                                   (No.2015-10-02)


NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES
OR FOR DISSEMINATION IN THE UNITED STATES.

GENVIEW CAPITAL CORP. PROVIDES UPDATE ON QUALIFYING TRANSACTION & RELATED TRANSACTIONS 
Vancouver, British Columbia - October 13, 2015 - Genview Capital Corp. ("Genview" or the "Company") (TSX Venture: GVW.
--->H) provides the following update with respect to a proposed share exchange with Dharma Distributors Ltd. dba Hempco Ca
--->nada Superfoods ("DDL"), pursuant to which Genview will acquire all of the issued and outstanding shares of DDL (the "
--->Transaction"), which shall constitute Genview's Qualifying Transaction as defined in the policies of the TSX Venture E
--->xchange (the "Exchange"). The Transaction is an arm's length transaction.
Bridge Financing
Genview is pleased to announce that DDL has closed the first tranche of a private placement of convertible notes (the 
--->"Offering"), whereby DDL issued convertible notes (each, a "Note") for aggregate proceeds of $225,000.  Upon closing o
--->f the Transaction between Genview and DDL, the principal amount of the Notes shall be automatically converted into pos
--->t-consolidated common shares of Genview (the "Conversion Shares") at a conversion price equal to 80% of the Issue Pric
--->e.  The "Issue Price" is the price per post-consolidated Genview common share at which Genview conducts a proposed com
--->mon share concurrent financing in connection with the Transaction.   The Notes bear interest at the rate of 10% per an
--->num, and are due in one year unless converted into Genview shares prior.
DDL is proceeding with a second tranche of the Offering for a total aggregate amount of up to $500,000.  The proceeds 
--->of the Offering are expected to be used for general corporate and working capital purposes. 
DDL Business Update
DDL has launched a new line of retail products under the PLANETHEMP brand name.  The new brand name will be featured o
--->n new product formulations as well as distinctive new packaging.  
DDL has also completed its refit of processing equipment and site upgrade at its processing facility located in Manito
--->ba.  The upgraded facilities were designed to meet the highest levels of HACCP, Food Safety and GMP standards.

Initial Exchange Submission & Proposed Director/Officer Update
Genview is pleased to announce that it has submitted its initial Exchange submission pursuant to Exchange Policy 2.4 -
---> Capital Pool Companies, which included, among other documents, a draft filing statement prepared in accordance with t
--->he Exchange form of filing statement (Form 3B2). Final acceptance by the Exchange is subject to the filing of further 
--->documents and information.  The Exchange has approved a waiver of sponsorship in connection with Genview's acquisition
---> of DDL, subject to the Transaction otherwise meeting Exchange requirements and certain other conditions.
Genview also announces that the parties have agreed on the proposed directors and officers of the Resulting Issuer, wh
--->ich are as follows:
Name
 Position
 
 Charles Holmes
 CEO and Director
 
 Angela Holmes
 COO and Director
 
 Praveen Varshney
 CFO and Director
 
 Lorne Gertner
 Director
 
 Mary-Lynn Bellamy-Willms
 Director
 
 Ravinder (Rob) Kang
 Corporate Secretary
 
 Biographies and full particulars of the Transaction will be disclosed in the filing statement, which will be filed un
--->der Genview's profile on SEDAR at www.sedar.com. 
About DDL
DDL is a private company incorporated on July 14, 2008 under the British Columbia Business Corporations Act and its he
--->ad office is located in Burnaby, British Columbia. Charles Holmes and Angela Holmes of British Columbia each hold 50% 
--->of the issued and outstanding common shares of DDL.
DDL is a trusted and respected pioneer, innovator and provider of value added hemp seed foods as a major food source f
--->or humans and animals. The Holmes family is well known in the hemp seed food industry and has been involved in the bus
--->iness of hemp seed food R&D, manufacturing, distribution and marketing for 15 years. The Holmes family is very excited
---> about the future of the hemp food industry and believes that now is excellent timing for major global expansion.  The
---> website for Hempco Canada is www.hempcocanada.com.
About Genview
Genview is a capital pool company under Policy 2.4 of the Exchange but was not able to complete a Qualifying Transacti
--->on within the prescribed time frame and applied for listing on the NEX Board of the Exchange.  Genview has no active b
--->usiness or operations and has no material assets other than cash.  The principal business of Genview consists of the i
--->dentification and evaluation of potential acquisitions or businesses, and once identified and evaluated, the negotiati
--->on of an acquisition or business combination, subject to receipt of regulatory and, if required, shareholder approval.
--->  
Trading Update
Investors are cautioned that, except as disclosed in the filing statement to be prepared in connection with the Transa
--->ction, any information released or received with respect to the Transaction may not be accurate or complete and should
---> not be relied upon.
The Genview Shares are currently halted from trading and shall remain so until completion of the Transaction, or until
---> satisfactory documentation to allow a resumption of trading is filed with and reviewed by the Exchange.
This press release should not be considered a comprehensive summary of the Transaction.  Additional information requir
--->ed by the Exchange will be disseminated at a future date following a satisfactory review by the Exchange. 
Trading of the Genview Shares will remain halted pending receipt and review by the Exchange of acceptable documentatio
--->n regarding Genview following completion of the Transaction. The proposed Transaction has not been approved by the Exc
--->hange and remains subject to Exchange acceptance. 
All information provided in this news release related to Genview has been provided by management of Genview and has no
--->t been independently verified by management of DDL.
All information provided in this news release related to DDL has been provided by management of DDL and has not been i
--->ndependently verified by management of Genview.

ON BEHALF OF THE BOARD OF DIRECTORS

GENVIEW CAPITAL CORP.

"PRAVEEN VARSHNEY"
_______________________
PRAVEEN VARSHNEY, CPA, CA
PRESIDENT & CEO

Reader Advisory
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to 
--->the proposal to complete the Transaction and associated transactions, including statements regarding the terms and con
--->ditions of the Transaction, the sponsorship waiver, the closing and use of proceeds of the Offering and the outlook of
---> the hemp food industry and the potential for DDL's global expansion. The information about DDL contained in the press
---> release has not been independently verified by the Company. Although the Company believes in light of the experience 
--->of its officers and directors, current conditions and expected future developments and other factors that have been co
--->nsidered appropriate that the expectations reflected in this forward-looking information are reasonable, undue relianc
--->e should not be placed on them because the Company can give no assurance that they will prove to be correct. Readers a
--->re cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ ma
--->terially from those contemplated by these statements depending on, among other things, the risks that the parties will
---> not proceed with the Transaction, the Offering, and associated transactions, that the ultimate terms of the Transacti
--->on, the Offering, the sponsorship waiver and associated transactions will differ from those that currently are contemp
--->lated, and that the Transaction, the Offering, the sponsorship waiver and associated transactions will not be successf
--->ully completed for any reason (including the failure to obtain the required approvals or clearances from regulatory au
--->thorities). The terms and conditions of the Transaction may change based on the Company's due diligence and the receip
--->t of tax, corporate and securities law advice for both the Company and DDL. The statements in this press release are m
--->ade as of the date of this release. The Company undertakes no obligation to comment on analyses, expectations or state
--->ments made by third-parties in respect of the Company, DDL, their securities, or their respective financial or operati
--->ng results (as applicable).
Completion of the Transaction is subject to a number of conditions, including but not limited to, Exchange acceptance 
--->and if applicable pursuant to Exchange Requirements, majority of the minority shareholder approval. Where applicable, 
--->the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the T
--->ransaction will be completed as proposed or at all.
Investors are cautioned that, except as disclosed in the management information circular or filing statement to be pre
--->pared in connection with the Transaction, any information released or received with respect to the transaction may not
---> be accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be 
--->considered highly speculative.
The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approve
--->d nor disapproved the contents of this press release.



© 2024 Canjex Publishing Ltd. All rights reserved.